OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Safety of Spironolactone in Patients with Resistant Hypertension: A Meta-analysis of Randomised Controlled Trials
Chunbin Wang, Bo Xiong, Jing Huang
Heart Lung and Circulation (2016) Vol. 25, Iss. 10, pp. 1021-1030
Closed Access | Times Cited: 52
Chunbin Wang, Bo Xiong, Jing Huang
Heart Lung and Circulation (2016) Vol. 25, Iss. 10, pp. 1021-1030
Closed Access | Times Cited: 52
Showing 26-50 of 52 citing articles:
A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension
Anita Paula Tataru, Arden R. Barry
American Journal of Cardiovascular Drugs (2017) Vol. 17, Iss. 4, pp. 311-318
Closed Access | Times Cited: 17
Anita Paula Tataru, Arden R. Barry
American Journal of Cardiovascular Drugs (2017) Vol. 17, Iss. 4, pp. 311-318
Closed Access | Times Cited: 17
Effectiveness of spironolactone dispensation in reducing weekly alcohol use: a retrospective high-dimensional propensity score-matched cohort study
Vanessa A. Palzes, Mehdi Farokhnia, Andrea H. Kline‐Simon, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2140-2147
Open Access | Times Cited: 13
Vanessa A. Palzes, Mehdi Farokhnia, Andrea H. Kline‐Simon, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2140-2147
Open Access | Times Cited: 13
Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?
JC Yugar-Toledo, V. Brunelli, José Fernando Vilela-Martin, et al.
Current Hypertension Reports (2018) Vol. 20, Iss. 3
Closed Access | Times Cited: 15
JC Yugar-Toledo, V. Brunelli, José Fernando Vilela-Martin, et al.
Current Hypertension Reports (2018) Vol. 20, Iss. 3
Closed Access | Times Cited: 15
Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement
Luca Faconti, George Casella, Sarah Partridge, et al.
Journal of Human Hypertension (2024)
Open Access | Times Cited: 1
Luca Faconti, George Casella, Sarah Partridge, et al.
Journal of Human Hypertension (2024)
Open Access | Times Cited: 1
Uncontrolled Arterial Hypertension: Kidney, Neurohormonal Imbalance, and Approaches to Antihypertensive Drug Therapy
Kuz'min Ob, N. V. Buchneva, В. В. Жежа, et al.
Kardiologiia (2019) Vol. 59, Iss. 12, pp. 64-71
Open Access | Times Cited: 10
Kuz'min Ob, N. V. Buchneva, В. В. Жежа, et al.
Kardiologiia (2019) Vol. 59, Iss. 12, pp. 64-71
Open Access | Times Cited: 10
Ambulatory Resistant Hypertension and Risk of Heart Failure in the Elderly
Francesca Coccina, Anna M. Pierdomenico, Chiara Cuccurullo, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 3
Francesca Coccina, Anna M. Pierdomenico, Chiara Cuccurullo, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1631-1631
Open Access | Times Cited: 3
Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension
Slobodan Јаnkovic, Siniša Stojković, Milovan Petrović, et al.
Medicine (2023) Vol. 102, Iss. 22, pp. e33941-e33941
Open Access | Times Cited: 3
Slobodan Јаnkovic, Siniša Stojković, Milovan Petrović, et al.
Medicine (2023) Vol. 102, Iss. 22, pp. e33941-e33941
Open Access | Times Cited: 3
Should All Patients with Resistant Hypertension Receive Spironolactone?
J. Rosa, Tomáš Zelinka, Ondřej Petrák, et al.
Current Hypertension Reports (2016) Vol. 18, Iss. 11
Closed Access | Times Cited: 6
J. Rosa, Tomáš Zelinka, Ondřej Petrák, et al.
Current Hypertension Reports (2016) Vol. 18, Iss. 11
Closed Access | Times Cited: 6
Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
Elizabeth do Espírito Santo Cestário, Letícia Aparecida Barufi Fernandes, Luiz Tadeu Giollo-Júnior, et al.
Trials (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Elizabeth do Espírito Santo Cestário, Letícia Aparecida Barufi Fernandes, Luiz Tadeu Giollo-Júnior, et al.
Trials (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Mineralocorticoid Receptor Antagonists in Essential and Resistant Hypertension
Κonstantinos Imprialos, Sofia Bouloukou, Georgios Kerpiniotis, et al.
Current Pharmaceutical Design (2019) Vol. 24, Iss. 46, pp. 5500-5507
Closed Access | Times Cited: 5
Κonstantinos Imprialos, Sofia Bouloukou, Georgios Kerpiniotis, et al.
Current Pharmaceutical Design (2019) Vol. 24, Iss. 46, pp. 5500-5507
Closed Access | Times Cited: 5
COUNTERPOINT: Should Sleep Studies Be Performed for All Patients With Poorly Controlled Hypertension? No
Claudia R.L. Cardoso, Gil F. Salles
CHEST Journal (2019) Vol. 155, Iss. 6, pp. 1097-1101
Open Access | Times Cited: 4
Claudia R.L. Cardoso, Gil F. Salles
CHEST Journal (2019) Vol. 155, Iss. 6, pp. 1097-1101
Open Access | Times Cited: 4
Turkish Society of Cardiology Consensus Paper on Evaluation and Treatment of Resistant Hypertension
Asife Şahinarslan, Emıne Gazı, Meryem Aktöz, et al.
The Anatolian Journal of Cardiology (2020)
Open Access | Times Cited: 4
Asife Şahinarslan, Emıne Gazı, Meryem Aktöz, et al.
The Anatolian Journal of Cardiology (2020)
Open Access | Times Cited: 4
Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project
Roman Bontsevich, Yana R. Vovk, Anna A. Gavrilova, et al.
Systemic Hypertension (2021) Vol. 18, Iss. 2, pp. 80-87
Open Access | Times Cited: 4
Roman Bontsevich, Yana R. Vovk, Anna A. Gavrilova, et al.
Systemic Hypertension (2021) Vol. 18, Iss. 2, pp. 80-87
Open Access | Times Cited: 4
Resistant Hypertension: Questions and Contemporary Answers
В. И. Подзолков, А. Е. Брагина, K. K. Osadchiy
Rational Pharmacotherapy in Cardiology (2019) Vol. 15, Iss. 4, pp. 568-577
Open Access | Times Cited: 3
В. И. Подзолков, А. Е. Брагина, K. K. Osadchiy
Rational Pharmacotherapy in Cardiology (2019) Vol. 15, Iss. 4, pp. 568-577
Open Access | Times Cited: 3
Efficacy of pharmacological and interventional treatment for resistant hypertension-a network meta-analysis
Zhejia Tian, Clara Vollmer Barbosa, Hannah Lang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Zhejia Tian, Clara Vollmer Barbosa, Hannah Lang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Pharmacotherapies for Cardiovascular Disease Prevention
Jennifer Ballard‐Hernandez, Colleen Walsh Irwin
Springer eBooks (2024), pp. 395-432
Closed Access
Jennifer Ballard‐Hernandez, Colleen Walsh Irwin
Springer eBooks (2024), pp. 395-432
Closed Access
Hypertension in the Elderly: Pathophysiology and Clinical Significance
Yook Chin Chia
Updates in hypertension and cardiovascular protection (2022), pp. 239-256
Closed Access | Times Cited: 2
Yook Chin Chia
Updates in hypertension and cardiovascular protection (2022), pp. 239-256
Closed Access | Times Cited: 2
Optimising Renin-Angiotensin-Aldosterone System Inhibitor Therapy in Heart Failure and Resistant Hypertension: Challenges and Solutions
Kaedy Bryson
European Medical Journal (2016), pp. 19-26
Open Access | Times Cited: 1
Kaedy Bryson
European Medical Journal (2016), pp. 19-26
Open Access | Times Cited: 1
Faculty Opinions recommendation of Resistant hypertension: detection, evaluation, and management: A scientific statement from the american heart association.
Athanasios Manolis
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2020)
Open Access | Times Cited: 1
Athanasios Manolis
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2020)
Open Access | Times Cited: 1
Hypertensive crisis: Diagnosis and treatment
Nevena Kalezić, Marina Stojanović, Nemanja Dimić, et al.
Galenika Medical Journal (2022) Vol. 1, Iss. 3, pp. 42-47
Open Access | Times Cited: 1
Nevena Kalezić, Marina Stojanović, Nemanja Dimić, et al.
Galenika Medical Journal (2022) Vol. 1, Iss. 3, pp. 42-47
Open Access | Times Cited: 1
Drug therapy of arterial hypertension: assessment of the senior students’ basic knowledge. Final results of the PHYSTARH project
Roman Bontsevich, Yana R. Vovk, V. K. Kotlyarova, et al.
Systemic Hypertension (2022) Vol. 19, Iss. 2, pp. 5-10
Open Access | Times Cited: 1
Roman Bontsevich, Yana R. Vovk, V. K. Kotlyarova, et al.
Systemic Hypertension (2022) Vol. 19, Iss. 2, pp. 5-10
Open Access | Times Cited: 1
Role of spironolactone in patients with resistant hypertension
Geeta Sheth, Kavita Joshi
Heart India (2021) Vol. 9, Iss. 1, pp. 3-11
Open Access | Times Cited: 1
Geeta Sheth, Kavita Joshi
Heart India (2021) Vol. 9, Iss. 1, pp. 3-11
Open Access | Times Cited: 1
POSICIONAMENTO BRASILEIRO SOBRE HIPERTENSÃO ARTERIAL RESISTENTE – 2020
Juan Carlos Yugar‐Toledo, Heitor Moreno, Miguel Gus, et al.
Revista Brasileira de Hipertensão (2020) Vol. 27, Iss. 2, pp. 41-58
Open Access
Juan Carlos Yugar‐Toledo, Heitor Moreno, Miguel Gus, et al.
Revista Brasileira de Hipertensão (2020) Vol. 27, Iss. 2, pp. 41-58
Open Access
Spironolacton in the therapy of resistant hypertension
Maja Milošević, Petar Otašević
Galenika Medical Journal (2022) Vol. 1, Iss. 1, pp. 29-37
Open Access
Maja Milošević, Petar Otašević
Galenika Medical Journal (2022) Vol. 1, Iss. 1, pp. 29-37
Open Access
